How the US Locked Up Vaccine Materials Other Nations Urgently Need medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Reuters Published: 08 May 2021 08:27 AM BdST Updated: 08 May 2021 08:27 AM BdST Stickers that are given to people who have been vaccinated against the coronavirus disease (COVID-19) are pictured in Los Angeles, California, US, April 12, 2021. REUTERS
To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots. ); }
As a result, the US government laid claim not only to vast quantities of finished COVID-19 vaccines but also to vaccine components and equipment all along the supply chain, according to a Reuters review of more than a dozen contracts involving some major suppliers.
By Syndicated Content
By Allison Martell and Euan Rocha
(Reuters) – To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.
As a result, the U.S. government laid claim not only to vast quantities of finished COVID-19 vaccines but also to vaccine components and equipment all along the supply chain, according to a Reuters review of more than a dozen contracts involving some major suppliers.
That has left some countries desperately in need of those supplies to scramble for substitutes, exacerbating international disparities in vaccine access, according to interviews with suppliers, foreign manufacturers and vaccine market experts.
Fri, 7th May 2021 16:00
By Allison Martell and Euan Rocha
May 7 (Reuters) - To fight the pandemic at home, the United
States gave its own vaccine manufacturers priority access to
American-made materials needed to make the shots.
As a result, the U.S. government laid claim not only to vast
quantities of finished COVID-19 vaccines but also to vaccine
components and equipment all along the supply chain, according
to a Reuters review of more than a dozen contracts involving
some major suppliers.
supplies to scramble for substitutes, exacerbating international
disparities in vaccine access, according to interviews with
suppliers, foreign manufacturers and vaccine market experts.